Streetbeat News

Stock Prices

EARN

Ellington Credit expects its Q3 adjusted distributed EPS to decline somewhat from the Q2 level of $0.36, while still exceeding the Q1 level of $0.27. The estimated EPS for Q3 is $0.29.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:50 pm

BMBL

FDCF

FMET

RVER

WCEO

Bumble Inc. (NASDAQ:BMBL) experienced a significant drop in stock price following a revenue miss and a lower-than-expected forecast for the third quarter. Despite the decline, Goldman Sachs maintained a Buy rating on the stock. ETFs tracking Bumble also showed mixed performance.

Portfolio Pulse from Michael Juliano

August 12, 2024 | 9:48 pm

EARN

Ellington Credit (NYSE:EARN) reported Q2 2024 adjusted EPS of $0.36, beating the analyst estimate of $0.28. However, sales were $3.90 million, missing the $4.13 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:47 pm

CTXR

Citius Pharma (NASDAQ:CTXR) reported a Q3 2024 GAAP EPS of $(0.06), missing the analyst consensus estimate of $(0.05) by 20%. This result is unchanged from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:41 pm

ENVB

Enveric Biosciences (NASDAQ:ENVB) reported a Q2 2024 GAAP EPS of $(0.23), significantly beating the analyst consensus estimate of $(0.55) by 58.18%.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:39 pm

SLND

Southland reveals confidence in its core business and long-term outlook despite challenges in its legacy business.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:35 pm

SLND

Southland Holdings (AMEX:SLND) reported Q2 2024 adjusted EPS of $(0.96), significantly missing the $0.02 estimate. Sales were $251.51M, also missing the $293.67M estimate.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:33 pm

ORCL

Oracle (NYSE:ORCL) has outperformed the market over the past 5 years with an average annual return of 19.86%, resulting in a $100 investment growing to $252.10. The company's current market capitalization is $365.37 billion.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 9:30 pm

ACM

AECOM (NYSE:ACM) has significantly outperformed the market over the past 5 years, delivering an average annual return of 23.58%. A $1000 investment in ACM 5 years ago would now be worth $2,926.94. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 9:30 pm

DYN

Dyne Therapeutics (NASDAQ:DYN) reported a Q2 2024 GAAP EPS of $(0.70), beating the analyst consensus estimate of $(0.72) by 2.78%. This represents a 35.19% improvement over the losses of $(1.08) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 9:19 pm